Role of epigenetics in Alzheimer's disease pathogenesis. (11th June 2018)

• Record Type: Journal Article
• Authors: Stoccoro, Andrea; Coppedè, Fabio
• Is Part Of: Neurodegenerative disease management. Volume 8:Number 3(2018)
• Page Start: 181
• Page End: 193
• Publication Date: 2018-06-11
• Subjects: Alzheimer's disease -- DNA hydroxymethylation -- DNA methylation -- epigenetics -- epigenetic drugs -- histone tail modifications -- mitochondrial epigenetics -- noncoding RNAs; Nervous system -- Degeneration -- Periodicals; 616.8
• DOI: 10.2217/nmt-2018-0004
• Languages: English
• ISSNs: 1758-2024

Abstract

Advances in molecular biology technologies have allowed uncovering the role of epigenetic regulation in several complex diseases, such as cancer and neurodegenerative disorders. Although the role of epigenetic mechanisms in Alzheimer's disease is still little understood, recent findings clearly show that such mechanisms are dysregulated during disease progression, already in its early stages. However, it is not clear if the observed epigenetic changes represent a cause or a consequence of the disease. Promising results are emerging from studies performed in peripheral blood DNA that could provide early biomarkers of the pathology. Moreover, given the dynamic nature of the epigenetic marks, intense research is carried out to investigate the therapeutic efficacy of compounds exerting epigenetic properties.